Monsanto's Glyphosate Herbicides: Study Found to Have "Serious Ethical Concerns"
A landmark study published 25 years ago by Regulatory Toxicology and Pharmacology journal has been formally retracted due to "serious ethical concerns" regarding its independence, accountability, and the academic integrity of the research presented. The paper, titled Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient Glyphosate for Humans, concluded that Monsanto's glyphosate-based weed killers posed no health risks to humans.
The study was authored by Gary Williams, Robert Kroes, and Ian Munro, three scientists who were not employed by Monsanto. The paper was cited as evidence of the safety of glyphosate herbicides by regulators worldwide, including the Environmental Protection Agency (EPA) in the US. However, internal company documents revealed that Monsanto had significant influence over the study, with emails showing how the company's "Freedom to Operate" strategy was closely tied to the research paper.
One email from Lisa Drake, a Monsanto government affairs official at the time, praised the work of seven employees who contributed to the paper, stating that it was "regarded as 'the' reference on Roundup and glyphosate safety." Another email suggested that ghostwritten papers could be used to support Monsanto's business plans, including using company logo polo shirts as a token of appreciation for researchers.
The retraction is a significant development in the ongoing debate over the safety of glyphosate herbicides. Critics have long argued that the study was flawed due to its reliance on unpublished research from Monsanto and potential conflicts of interest among the authors. The EPA has stated that it has "extensively studied glyphosate, reviewing more than 6,000 studies across all disciplines," but the agency is currently conducting a new human health risk assessment for the chemical.
Brent Wisner, one of the lead lawyers in the Roundup litigation, said the retraction was long overdue and highlighted the need for greater transparency and accountability in scientific research. "This study finally got the fate it deserved," he said. The retraction is seen as a major blow to Bayer's efforts to defend its glyphosate herbicides against thousands of lawsuits claiming they cause cancer.
A landmark study published 25 years ago by Regulatory Toxicology and Pharmacology journal has been formally retracted due to "serious ethical concerns" regarding its independence, accountability, and the academic integrity of the research presented. The paper, titled Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient Glyphosate for Humans, concluded that Monsanto's glyphosate-based weed killers posed no health risks to humans.
The study was authored by Gary Williams, Robert Kroes, and Ian Munro, three scientists who were not employed by Monsanto. The paper was cited as evidence of the safety of glyphosate herbicides by regulators worldwide, including the Environmental Protection Agency (EPA) in the US. However, internal company documents revealed that Monsanto had significant influence over the study, with emails showing how the company's "Freedom to Operate" strategy was closely tied to the research paper.
One email from Lisa Drake, a Monsanto government affairs official at the time, praised the work of seven employees who contributed to the paper, stating that it was "regarded as 'the' reference on Roundup and glyphosate safety." Another email suggested that ghostwritten papers could be used to support Monsanto's business plans, including using company logo polo shirts as a token of appreciation for researchers.
The retraction is a significant development in the ongoing debate over the safety of glyphosate herbicides. Critics have long argued that the study was flawed due to its reliance on unpublished research from Monsanto and potential conflicts of interest among the authors. The EPA has stated that it has "extensively studied glyphosate, reviewing more than 6,000 studies across all disciplines," but the agency is currently conducting a new human health risk assessment for the chemical.
Brent Wisner, one of the lead lawyers in the Roundup litigation, said the retraction was long overdue and highlighted the need for greater transparency and accountability in scientific research. "This study finally got the fate it deserved," he said. The retraction is seen as a major blow to Bayer's efforts to defend its glyphosate herbicides against thousands of lawsuits claiming they cause cancer.